Sensible Medicine

AUGUST 21, 2023

On yesterday’s podcast , I talked with Bobby Yeh, an academic cardiologist who made a compelling case for enhancing credibility of observational research. This is a common probably insurmountable problem with morbidities, such as hypertension, diabetes , COPD , etc. Please do listen. It is our goal. Thanks for your support.

Administration 98

Administration Outcomes Research COPD 98

Dr. Smith's ECG Blog

JANUARY 5, 2020

This 60-something with h/o COPD and HFrEF (EF 25%) presented with SOB and chest pain. M Y A NSWER: In my opinion — it is both academic and clinically unimportant ( as well as often impossible ) to attempt to distinguish between sinus rhythm with multiple different-looking PACs vs MAT. Here is the ECG: What do you think?

EKG/ECG 52

EKG/ECG COPD Wellness Sepsis 52

PulmCCM

OCTOBER 23, 2023

Over the years, dozens of copycat studies (which are relatively easy for academics to churn out) created a steady, low-quality drumbeat of negativity toward Zosyn. Even people with COPD or asthma under age 50 did not benefit from Paxlovid, in that analysis.

Hospitals 98

Hospitals COPD Emergency Department CDC 98

PulmCCM

SEPTEMBER 28, 2023

Read in NEJM Prevalence of pulmonary embolism during COPD exacerbations Pulmonary embolism (PE) and acute exacerbations of chronic obstructive pulmonary disease (COPD) can present with similar symptoms of dyspnea, hypoxemia, and cough.

COPD 95

COPD Stroke Academics Urgent Care 95